Late stage investors in the United Kingdom
Updated 16 Nov 2026
Venture funds
9 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Balderton Capital Balderton Capital supports technology businesses, recently backing Primer and Sava Technology. London, United Kingdom |
Fintech, Artificial intelligence | Seed, Early stage venture, Late stage venture | 45% | 3 |
| 2 | Hedosophia Hedosophia supports category-defining technology companies globally, with recent backings including Pennylane and PolyAI. London, United Kingdom |
Fintech, Artificial intelligence | Seed, Early stage venture, Late stage venture | 42% | 3 |
| 3 | IP Group IP Group commercializes intellectual property into businesses, with recent investments in Microbiotica and Oxford Quantum Circuits. London, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 19% | 3 |
| 4 | Octopus Ventures Octopus Ventures supports companies from idea conception to IPO, including Living Optics and Edgify. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 54% | 3 |
| 5 | Oxford Science Enterprises Oxford Science Enterprises is a university-partnered firm investing in life science, AI and deep tech, recently backing Fractile and Salience Labs. Oxford, United Kingdom |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 41% | 3 |
| 6 | Parkwalk Advisors Parkwalk Advisors invests in UK technology companies spun out of universities and research centres, with recent companies including Adsilico and Oxford Quantum Circuits. London, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 27% | 3 |
| 7 | SoftBank Vision Fund SoftBank Vision Fund makes growth capital and social impact investments, with recent companies including WHOOP and Opentrons. London, United Kingdom |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 71% | 3 |
| 8 | Firstminute Capital Firstminute Capital invests in pre-seed and seed technology companies, including Mural and Automata. London, United Kingdom |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 26% | 2 |
| 9 | Future Planet Capital London, United Kingdom |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 3% | 2 |
Table 1. Late stage investors in the United Kingdom: venture capital and micro VC funds ranked by companies whose Series C and later round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Octopus Ventures | Venture capital firm | London, United Kingdom | •••@octopusvnetures.com | +44 20••• |
| Balderton Capital | Venture capital firm | London, United Kingdom | •••@balderton.com | +44 (0••• |
| 3i Group | Private equity firm | London, United Kingdom | •••@3i.com | 44 (0)••• |
| LocalGlobe | Micro VC fund | London, United Kingdom | •••@localglobe.vc | |
| British International Investment | Government investment office | London, United Kingdom | •••@bii.co.uk | +44 (0••• |
| Future Planet Capital | Venture capital firm | London, United Kingdom | •••@futureplanetcapital.com | +44 79••• |
| Scottish Investment Bank | Investment bank | Glasgow, United Kingdom | •••@scotent.co.uk | |
| Parkwalk Advisors | Venture capital firm | London, United Kingdom | •••@parkwalkadvisors.com | +44 20••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| Lars Fjeldsoe-Nielsen | A••• P••• | Co-Founder and Managing Partner | a•••@owlvc.com | In the CSV |
| Louis Frach | V••• P••• | Managing Partner, co-founder | v•••@leftlane.com | In the CSV |
| Toby Triebel | F••• K••• | Managing Partner | f•••@fintech.io | In the CSV |
| Andreas Weiskam | A••• W••• | Managing Director | a•••@sapphireventures.com | In the CSV |
| Nazo Moosa | S••• K••• | Managing Partner, Frontier | k•••@energyimpactpartners.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 356 of the 637 late stage investors in the United Kingdom have a published email address, 274 a phone number and 546 a website.
- Eight Roads Ventures has the most recorded investments, 552, 236 of them as lead investor.
- 90 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Parkwalk Advisors is an investor in 10 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is T-Therapeutics' $133.0M Series B on 5 November 2026.
- Software is the most common sector across their 2,401 portfolio companies (77%).
- Early stage venture is the most common investment stage, recorded for 473 of them (74%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Late stage investors in the United Kingdom
30 of 637, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | Fintech, Health care | Kaiko, Sonosemi Medical, Exponent Energy | 8 | 552 | 236 | 134 | +91 80••• | In the CSV | |
| 2 | Octopus Ventures | Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Living Optics, Metris Energy, Edgify | 9 | 477 | 259 | 73 | •••@octopusvnetures.com | +44 20••• | In the CSV |
| 3 | Balderton Capital | Venture capital firm | London, United Kingdom | Fintech, Artificial intelligence | Sava Technology, TILT, Primer | 7 | 477 | 216 | 98 | •••@balderton.com | +44 (0••• | In the CSV |
| 4 | 3i Group | Private equity firm, Venture capital firm | London, United Kingdom | Hardware, Health care | Twenga, Endosense, OmniGuide | 476 | 140 | 195 | •••@3i.com | 44 (0)••• | In the CSV | |
| 5 | SoftBank Vision Fund | Private equity firm, Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Opentrons, WHOOP, Early Health | 4 | 471 | 334 | 91 | +44 02••• | In the CSV | |
| 6 | LocalGlobe | Micro VC fund, Venture capital firm | London, United Kingdom | Artificial intelligence, Fintech | Breedr, CuspAI, Early Health | 4 | 451 | 141 | 89 | •••@localglobe.vc | In the CSV | |
| 7 | British International Investment | Government investment office, Venture capital firm | London, United Kingdom | Fintech, Health care | Paymob | 1 | 432 | 140 | 81 | •••@bii.co.uk | +44 (0••• | In the CSV |
| 8 | HSBC | Investment bank | London, United Kingdom | Artificial intelligence, Fintech | Quantexa, Prophecy.io, Ampd Energy | 364 | 146 | 114 | +44 20••• | In the CSV | ||
| 9 | Future Planet Capital | Venture capital firm | London, United Kingdom | Biotech, Health care | Luffy AI, Captura, CellCentric | 4 | 360 | 12 | 27 | •••@futureplanetcapital.com | +44 79••• | In the CSV |
| 10 | Scottish Investment Bank | Investment bank, Private equity firm | Glasgow, United Kingdom | Hardware, Cybersecurity | Zumo, Speech Graphics, Boundary | 350 | 40 | 42 | •••@scotent.co.uk | In the CSV | ||
| 11 | Northzone | Venture capital firm | London, United Kingdom | Artificial intelligence, Fintech | Rayon, Tandem Health, Monumental | 6 | 347 | 148 | 60 | +46 85••• | In the CSV | |
| 12 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | OSSTEC, Adsilico, Reclinker | 10 | 339 | 91 | 32 | •••@parkwalkadvisors.com | +44 20••• | In the CSV |
| 13 | IP Group | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | Microbiotica, Oxford Quantum Circuits, Oxa | 3 | 304 | 59 | 38 | •••@ipgroupplc.com | +44 (0••• | In the CSV |
| 14 | Amadeus Capital Partners | Venture capital firm | Cambridge, United Kingdom | Artificial intelligence, Hardware | iPronics, Tenzo, Refute | 5 | 293 | 86 | 64 | •••@amadeuscapital.com | +44 33••• | In the CSV |
| 15 | Atomico | Venture capital firm | London, United Kingdom | Artificial intelligence, Commerce | Early Health, Tem-Energy, Iconic | 3 | 285 | 110 | 56 | •••@atomico.com | +44 20••• | In the CSV |
| 16 | Anthemis | Venture capital firm | London, United Kingdom | Fintech, Artificial intelligence | Kaiko, Provable Markets | 2 | 275 | 100 | 40 | •••@anthemis.com | 442036••• | In the CSV |
| 17 | MMC Ventures | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | Stanhope AI, Built AI | 2 | 250 | 97 | 35 | •••@mmc.vc | +44 20••• | In the CSV |
| 18 | Apax Partners | Private equity firm | London, United Kingdom | Hardware, Commerce | Guesty, GAN Integrity, Pop Meals | 243 | 94 | 121 | •••@apax.com | +44 20••• | In the CSV | |
| 19 | Molten Ventures | Venture capital firm | London, United Kingdom | Artificial intelligence, Fintech | Pliant | 1 | 240 | 119 | 61 | •••@molten.vc | +44 20••• | In the CSV |
| 20 | Janus Henderson Investors | Private equity firm, Venture capital firm | London, United Kingdom | Health care, Biotech | Claris Biotherapeutics | 1 | 240 | 34 | 144 | •••@janushenderson.com | +44 (0••• | In the CSV |
| 21 | Foresight Group | Private equity firm, Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Cornelis Networks | 1 | 236 | 138 | 43 | •••@foresightgroup.eu | 44 (0)••• | In the CSV |
| 22 | 83North | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | Orbem, LinearB | 2 | 232 | 66 | 35 | +972 (••• | In the CSV | |
| 23 | Target Global | Venture capital firm | London, United Kingdom | Fintech, Artificial intelligence | Fresha | 1 | 226 | 94 | 28 | •••@targetglobal.vc | +44 20••• | In the CSV |
| 24 | Maven Capital Partners | Private equity firm, Venture capital firm | Glasgow, United Kingdom | Artificial intelligence, Hardware | Connected Data, Novatus Global, RwHealth | 225 | 162 | 39 | •••@mavencp.com | 0141 3••• | In the CSV | |
| 25 | Baillie Gifford | Private equity firm | Edinburgh, United Kingdom | Biotech, Health care | TEKEVER, Cosm | 2 | 215 | 53 | 55 | •••@bailliegifford.com | 44 (0)••• | In the CSV |
| 26 | Salica | Venture capital firm | London, United Kingdom | Fintech, Artificial intelligence | Semble, Neuphonic, Popcorn AI | 3 | 208 | 58 | 25 | •••@salicainvest.com | +44 20••• | In the CSV |
| 27 | Venrex | Venture capital firm | London, United Kingdom | Commerce, Hardware | Chexy | 1 | 199 | 69 | 21 | In the CSV | ||
| 28 | Abingworth | Private equity firm, Venture capital firm | London, United Kingdom | Biotech, Health care | Timberlyne Therapeutics, Myricx Bio, Anjarium Biosciences | 196 | 56 | 90 | •••@abingworth.com | (207) ••• | In the CSV | |
| 29 | Firstminute Capital | Venture capital firm | London, United Kingdom | Artificial intelligence, Fintech | Mural, Restate, Risk Ledger | 9 | 194 | 51 | 19 | •••@firstminute.capital | +44 (0••• | In the CSV |
| 30 | Oxford Capital | Venture capital firm | Oxford, United Kingdom | Fintech, Artificial intelligence | Noggin HQ | 1 | 190 | 49 | 20 | •••@oxcp.com | 01865 ••• | In the CSV |
Table 2. Late stage investors in the United Kingdom: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 637.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Parkwalk Advisors | London, United Kingdom | 10 | 38 | OSSTEC, Adsilico, Reclinker |
| 2 | Firstminute Capital | London, United Kingdom | 9 | 57 | Mural, Restate, Risk Ledger |
| 3 | Octopus Ventures | London, United Kingdom | 9 | 122 | Living Optics, Metris Energy, Edgify |
| 4 | Eight Roads Ventures | London, United Kingdom | 8 | 106 | Kaiko, Sonosemi Medical, Exponent Energy |
| 5 | Oxford Science Enterprises | Oxford, United Kingdom | 7 | 25 | Fractile, Quantrol Ox, Salience Labs |
| 6 | Balderton Capital | London, United Kingdom | 7 | 80 | Sava Technology, TILT, Primer |
| 7 | Northzone | London, United Kingdom | 6 | 60 | Rayon, Tandem Health, Monumental |
| 8 | Seraphim Space | London, United Kingdom | 6 | 29 | ElevationSpace, AADYAH Aerospace, ATMOS Space Cargo |
| 9 | Amadeus Capital Partners | Cambridge, United Kingdom | 5 | 36 | iPronics, Tenzo, Refute |
| 10 | SoftBank Vision Fund | London, United Kingdom | 4 | 71 | Opentrons, WHOOP, Early Health |
| 11 | LocalGlobe | London, United Kingdom | 4 | 98 | Breedr, CuspAI, Early Health |
| 12 | Future Planet Capital | London, United Kingdom | 4 | 31 | Luffy AI, Captura, CellCentric |
| 13 | Hedosophia | London, United Kingdom | 4 | 25 | Pivot, Candex, Pennylane |
| 14 | Unilever Ventures | London, United Kingdom | 4 | 23 | ClayCo. Cosmetics, Create Wellness, SkinInspired |
| 15 | Cambridge Innovation Capital | Cambridge, United Kingdom | 3 | 11 | T-Therapeutics, Microbiotica, Salience Labs |
Table 3. Late stage investors in the United Kingdom: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | Cambridge Innovation Capital, University of Cambridge Enterprise | 51 to 100 | 2022 |
| Firmly.ai | Firmly.ai operates an agentic commerce platform for product discovery and checkout across AI and digital channels. | Fintech | Seattle, United States | Series A | $15.0M | 2026-11-05 | $17.0M | Rapyd Ventures | 51 to 100 | 2019 |
| Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon, Switzerland | Series B | $160.0M | 2026-11-04 | $196.0M | The Capital Partnership | 1 to 10 | 2020 |
| Pliant | Pliant provides modular, API-first B2B payment solutions for businesses. | Fintech | Berlin, Germany | Series C | $80.0M | 2026-11-04 | $305.1M | Molten Ventures | 251 to 500 | 2020 |
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London, United Kingdom | Series A | $8.0M | 2026-11-03 | $12.7M | Parkwalk Advisors | 11 to 50 | 2021 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh, United Kingdom | Series A | $3.3M | 2026-11-02 | $17.4M | Archangels | 11 to 50 | 2020 |
| Fractile | Fractile develops semiconductor hardware and AI inference systems for large language model processing. | Artificial intelligence | London, United Kingdom | Series C | $771.2M | 2026-10-29 | $1.0B | Oxford Science Enterprises | 101 to 250 | 2022 |
| Opentrons Unicorn | Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. | Artificial intelligence | Long Island City, United States | Series E | $40.0M | 2026-10-29 | $300.2M | SoftBank Vision Fund | 251 to 500 | 2014 |
| Onego Bio | Onego Bio produces egg protein through fermentation as a food ingredient. | Biotech | Helsinki, Finland | Series B | $28.0M | 2026-10-26 | $100.6M | NordicNinja VC | 11 to 50 | 2022 |
| Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds, United Kingdom | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors, Northern Gritstone | 1 to 10 | 2022 |
Table 4. Late stage investors in the United Kingdom: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 1,838 | 77% |
| Fintech | 547 | 23% |
| Artificial intelligence | 505 | 21% |
| Hardware | 378 | 16% |
| Commerce | 274 | 11% |
| Health care | 245 | 10% |
| Biotech | 118 | 5% |
| Cybersecurity | 109 | 5% |
| Education | 95 | 4% |
| Energy | 48 | 2% |
Table 5. Late stage investors in the United Kingdom: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Late stage investors | 637 | 100% |
| Early stage investors | 473 | 74% |
| Seed investors | 299 | 47% |
| Venture investors | 250 | 39% |
| Private equity investors | 204 | 32% |
| Debt investors | 66 | 10% |
| Secondary market investors | 49 | 8% |
| Post IPO investors | 45 | 7% |
Table 6. Late stage investors in the United Kingdom by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Investors | Share |
|---|---|---|
| London | 532 | 84% |
| Edinburgh | 8 | 1% |
| Cambridge | 5 | 1% |
| Oxford | 5 | 1% |
| Manchester | 4 | 1% |
| Glasgow | 3 | 0% |
| Sheffield | 3 | 0% |
| Warrington | 3 | 0% |
| Aberdeen | 3 | 0% |
| Madingley | 2 | 0% |
| Bristol | 2 | 0% |
| Birmingham | 1 | 0% |
Table 7. Late stage investors in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 63 | 14% |
| 2010s | 189 | 42% |
| 2000s | 107 | 24% |
| 1990s | 47 | 11% |
| 1980s | 20 | 4% |
| 1970s | 3 | 1% |
Table 8. Late stage investors in the United Kingdom by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include late stage investors and its headquarters is in the United Kingdom. On 16 November 2026 that is 637 investors.
- 356 rows carry an email address and 274 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 637 rows: 91 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many late stage investors in the United Kingdom are on the list?
- 637, in the file dated 16 November 2026. 90 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 356 of the 637 carry an email address in the download and 274 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 637 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV with 637 rows, 356 firm email addresses and 274 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 288 of the 356 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.